ArticleFrontiers in pharmacology2017

Safety and Immunogenicity of a Human Epidermal Growth Factor Receptor 1 (HER1)-Based Vaccine in Prostate Castration-Resistant Carcinoma Patients: A Dose-Escalation Phase I Study Trial.

Iraida Caballero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.